发明名称 NEW CALCIUM ANTAGONIST
摘要 PROBLEM TO BE SOLVED: To obtain a strong and safe calcium antagonist useful as a therapeutic medicine for ischemic heart diseases, e.g. cardiotonic agents or cardiac infarction by including an uridine alkylphosphate compound as an active ingredient. SOLUTION: This calcium antagonist comprises an uridine 5'-alkyl phosphate compound of the formula (R is an alkyl), e.g. uridine 5'-hexadecyl phosphate an active ingredient. The compound of the formula is obtained by dissolving, e.g. uridine 5'-monophosphate and an alkyl alcohol in tert-butyl alcohol and reacting uridine 5'-monophosphate in the presence of dicyclohexylcarbodiimide usually at 60-100 deg.C for 2-20 hr. The compound of the formula can be administered by oral, parenteral, transrectal or percutaneous administration and the compound is preferably administered to each of adult patients at a daily total dose of 1-2,000 mg in the case of oral administration and 0.1-400 mg in the case of parenteral administration.
申请公布号 JP2000247891(A) 申请公布日期 2000.09.12
申请号 JP19990051114 申请日期 1999.02.26
申请人 FUSO PHARMACEUTICAL INDUSTRIES LTD 发明人 TANAKA TOSHIO;SUGAYA JUNKO;KISHI YUICHIRO;MATSUKAWA AKIRA
分类号 C07H19/10;A61K31/00;A61K31/70;A61K31/7042;A61K31/7052;A61K31/706;A61K31/7064;A61K31/7068;A61K31/7072;A61P7/00;A61P7/02;A61P43/00;(IPC1-7):A61K31/707 主分类号 C07H19/10
代理机构 代理人
主权项
地址